Neuriva

In June 2020, a class-action lawsuit was filed against Reckitt Benckiser for allegedly falsely marketing the supplements Neuriva Original and Neuriva Plus as “clinically proven” to improve “brain performance” – including focus, memory, learning, accuracy, concentration, and reasoning – when, according to plaintiffs, the company has no scientific or clinical proof that the products or ingredients in them provide the advertised benefits. (Matthews et al v. Reckitt Benckiser LLC and RB Health (US) LLC, Case No. 20-cv-854, E.D. Cal.)

For more of TINA.org’s coverage of brain supplements, click here.

Print Friendly, PDF & Email

Tags: ,



Leave a Reply

Back to Top ↑
  • Search Class-Action Tracker



  • Recent Class Actions

  • The Class-Action Tracker is intended to notify consumers about false advertising class-action lawsuits filed around the country, but does not necessarily reflect TINA.org’s opinion with respect to the lawsuits or disposition of the cases

  • Sign Up for E-mail Updates